Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | DS-7300a |
Synonyms | |
Therapy Description |
DS-7300a is a monoclonal antibody to B7-H3 (CD276), conjugated to the DNA topoisomerase I inhibitor and exatecan (DX-8951) derivative DXd , MAAA-1181 (NCI Thesaurus). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
DS-7300a | DS7300a|DS 7300a|DS7300|DS 7300|DS-7300 | CD276 Antibody 8 | DS-7300a is a monoclonal antibody to B7-H3 (CD276), conjugated to the DNA topoisomerase I inhibitor and exatecan (DX-8951) derivative DXd , MAAA-1181 (NCI Thesaurus). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05280470 | Phase II | DS-7300a | DS-7300a in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC) | Active, not recruiting | USA | FRA | ESP | 4 |
NCT04145622 | Phase Ib/II | DS-7300a | Study of DS-7300a in Participants With Advanced Solid Malignant Tumors | Recruiting | USA | 1 |